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Case presentation
A 5-year-9month old Chinese girl presented with severe
growth retardation, height SDS -4.17 and body weight
SDS -2.37. The mid-parental height was 151.2cm (3rd-10th
centile). She was born small for gestational age with no
catch-up growth. Congenital anomalies including right
dysplastic kidney and large secundum atrial septal defect
were present. She had delayed development with microce-
phaly and dysmorphism, including triangular facies,
epicanthic folds, low set ears, micronagthia, and brachy-
dactyly. Ophthalmological assessment showed astigma-
tism, myopia, and left exotropia requiring surgical
correction. Audiology assessment showed bilateral mild
conductive hearing loss. Thyroid function, morning corti-
sol, serum calcium and renal function tests were normal.
Metabolic disease workup including lactate, plasma for
amino acid, urine metabolic screen, VLCFA, transferrin
isoelectrofocusing and clotting profile were normal.
CT and MRI brain were normal. Serum IGF-1 at 13 years
old was 62nmol/L (+ 0.5SD). Growth hormone study with
glucagon showed peak growth hormone of 32mg/L. Bone
age was 12 years at chronological age of 12-year-10month.
Radiograph of both hands showed brachydactyly but no
proximal implantation of 1st digit. Genetic study show
normal karyotype, but MLPA and FISH later confirmed
heterozygous terminal deletion of 15q26.2 with the genetic
defect compatible with IGF-1 receptor mutation. Growth
hormone therapy was refused by the patient and mother.
Breast development started at 12-year-4month and
menarche started at 13-year-5month of age. The growth
spurt was absent with peak growth velocity of only 5.5cm/
year. On the latest follow-up at 13-year-9month of age,
her height was 128.8cm (-4.7SDS).
Discussion
Our patient displayed typical phenotypic features of IGF-1
receptor mutation of heterozygous deletion of 15q26.2
with severe growth retardation. The condition could
potentially benefit from growth hormone treatment
according to recent literatures [1]. Our report highlights
the importance of investigating for genetic causes of short
stature in patients with concomitant dysmorphism and
growth retardation.
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